- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
April 17th, 2007
Representatives from Merck will make a special presentation to researchers and scientists in universities and companies at the Nanotech 2007 conference on May 23, 2007 at the Santa Clara Convention Center in California.
Merck recently acquired Sirna Therapeutics, a leader in efforts to create RNAi-based therapeutics that could significantly alter the treatment of disease. RNAi-based therapeutics selectively catalyze the destruction of the RNA transcribed from an individual gene enabling an novel approach to discovering drugs with the potential to produce highly specific, potent, and long-lasting effects.
|Related News Press|
Nanoparticle therapy that uses LDL and fish oil kills liver cancer cells February 9th, 2016
Leading bugs to the death chamber: A kinder face of cholesterol February 8th, 2016
UTHealth research looks at nanotechnology to help prevent preterm birth February 7th, 2016
Chemical cages: New technique advances synthetic biology February 10th, 2016
Superconductivity: Footballs with no resistance - Indications of light-induced lossless electricity transmission in fullerenes contribute to the search for superconducting materials for practical applications February 9th, 2016
SUNY Poly and GLOBALFOUNDRIES Announce New $500M R&D Program in Albany To Accelerate Next Generation Chip Technology: Arrival of Second Cutting Edge EUV Lithography Tool Launches New Patterning Center That Will Generate Over 100 New High Tech Jobs at SUNY Poly February 9th, 2016
NBC LEARN DEBUTS SIX-PART VIDEO SERIES, “NANOTECHNOLOGY: SUPER SMALL SCIENCE” Produced by NBC Learn in partnership with the National Science Foundation, and narrated by NBC News/MSNBC’s Kate Snow, series highlights leading research in nanotechnology January 25th, 2016